• Department of Respiratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Shanghai,200025, China Corresponding Author: SHI Guo-chao, E-mail: shiguochao@ hotmail. com;
Export PDF Favorites Scan Get Citation

Objective  Chronic obstructive pulmonary disease( COPD) is highly heterogeneous. In theory, the patients with same clinical manifestations, treatment response and prognosis can be classified into one phenotype, which may have same biological or physiological mechanisms. In this study the profiles of patients with COPD including body mass index( BMI) , Goddard score, fractional exhaled nitric oxide( FeNO) were analyzed in order to find some special phenotypes.
Methods  Patients with COPD at stable stage in Ruijin Hospital from May 2011 to February 2012 were evaluated with COPD assessment test ( CAT) in Chinese version, St. George’s Respiratory Questionnaire( SGRQ) , hospital anxiety and depression( HAD) rating scale, pulmonary function test, and 6-minute walking test ( 6MWT) . Baseline data was collected including height, weight, drug use, times of exacerbation, etc.
Results  A total of 126 patients were recruited. The patients with low BMI had poorer quality of life, lower FEV1 , poorer diffusion function, and higher Goddard score, and was easier to develop anxiety and depression. The patients with high BMI had lower oxygen saturation at rest. We failed to define a certain kind of phenotype according to FeNO. The patients of emphysema phenotype( assessed by Goddard score) had lower BMI, decreased lung diffusion capacity, and poorer quality of life.
Conclusion  The study can define COPD patients into some special phenotypes( low BMI and emphysema phenotype) , but failed to define a certain kind of phenotype according to FeNO.

Citation: CAI Xiaoting,SHI Guochao,WAN Huanying,ZHOUMin,CHENGQijian,DAI Ranran.. The Clinical Features of Chronic Obstructive Pulmonary Disease according to Body Mass Index, Fractional Exhaled Nitric Oxide and Goddard Score. Chinese Journal of Respiratory and Critical Care Medicine, 2013, 12(3): 223-227. doi: 10 . 7507 /1671 -6205 . 20130054 Copy

  • Previous Article

    Role of AKT/FOXOs/Atrogin-1/MuRF1 Signalling Pathway in Skeletal Muscle Atrophy in COPD Rats
  • Next Article

    FEV6 as A Surrogate for FVC in the Diagnosis for Mild-Moderate Chronic Obstructive Pulmonary Disease